This is a delivery order contract awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of Spiriva Respimat 2.5 mcg inhalation medication. The contract has a ceiling value of $2,388.66 and a completion date of May 25, 2023. It is a firm fixed-price contract classified as a delivery order, with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor. This contract is part of a larger Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the supply of Spiriva Respimat 1.25 MCG inhalation medication with a ceiling value of $2,880.80. The contract is a firm-fixed price delivery order with an ultimate completion date of September 24, 2024. This contract is not set aside for any special business category. AmerisourceBergen is a major supplier of pharmaceutical products and...
This contract represents a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,145.56, is for the supply of Spiriva Respimat 2.5 mcg inhalation medication in a 4 gram quantity. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4,561,095,220 units of Spiriva Respimat 1.25 mcg inhalation medication. The contract has a firm fixed price of $2,460.29 and a completion date of June 1, 2023. AmerisourceBergen, a subsidiary of the parent company Cencora, Inc., holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to...
This is a Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,602.25, is for the provision of Spiriva Respimat 2.5 mcg inhalation medication. The contract has an ultimate completion date of December 11, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of Spiriva Respimat 1.25 mcg inhalation solution. The contract has a ceiling value of $2,616.80 and runs through September 10, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded this as a firm-fixed-price contract. The company has also been awarded multiple Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical and the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the supply of Spiriva Respimat 2.5 mcg Inhalation Aerosol in 4 gram units. The contract has an ultimate completion date of January 4, 2024, and a ceiling value of $2,340.45. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The award, valued at $5,560.32, is for the delivery of Spiriva Respimat 2.5 mcg inhalation medication. The contract is a Firm Fixed Price Delivery Order with a completion date of September 19, 2024. AmerisourceBergen, through its Corporate Office Division, will supply this respiratory medication to support government healthcare programs. The...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Spiriva Respimat 2.5 mcg inhalation medication. The $2,458.64 firm-fixed-price contract has a completion date of March 9, 2023 and does not have a set-aside designation, indicating open competition. AmerisourceBergen, a subsidiary of the parent company Cencora, Inc., holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division for the supply of 4,565,736,111 units of Spiriva Respimat 1.25 mcg inhalational medication, with a ceiling value of $3,271.00. The contract has an ultimate completion date of September 10, 2024 and is a firm fixed-price delivery order. This award is not associated with a set-aside program. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that holds...